Dr Kimberly Dawn Hill, PHARMD is a
Pharmacist based in Campbellton, Florida. Dr Kimberly Dawn Hill is licensed to practice in Alabama (license number 19241) and her current practice location is
2548 Overpass Rd, Campbellton, Florida. She can be reached at her office (for appointments etc.) via phone at
(850) 263-4489.
NPI number for Dr Kimberly Dawn Hill is 1508977901 and her current mailing address is 2548 Overpass Rd, Campbellton, Florida. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1508977901.
Healthcare Provider's Profile
Full Name | Dr Kimberly Dawn Hill |
---|
Gender | Female |
---|
Speciality | Pharmacist |
---|
Location | 2548 Overpass Rd, Campbellton, Florida |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1508977901
- Provider Enumeration Date: 08/31/2006
- Last Update Date: 08/25/2016
Medical Identifiers
Medical identifiers for Dr Kimberly Dawn Hill such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1508977901 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
183500000X | Pharmacist | 19241 (Alabama) | Primary |
1835P1200X | Pharmacist - Pharmacotherapy | 2564 (Wyoming) | Secondary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kimberly Dawn Hill is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Dr Kimberly Dawn Hill, PHARMD 2548 Overpass Rd, Campbellton, FL 32426-7118 Ph: (850) 263-4489 | Dr Kimberly Dawn Hill, PHARMD 2548 Overpass Rd, Campbellton, FL 32426-7118 Ph: (850) 263-4489 |
Reviews and Comments